DUBLIN--(BUSINESS WIRE)--Dec. 12, 2012--
plc (NYSE: COV) will report first-quarter results on January 25, 2013,
before trading begins. The Company will hold a conference call for
investors at 8:30 a.m. ET. The call can be accessed in the following
At Covidien’s website: http://investor.covidien.com
By telephone: For both “listen-only” participants and those
participants who wish to take part in the question-and-answer portion
of the call, the telephone dial-in number in the U.S. is 800-561-2693.
For participants outside the U.S., the dial-in number is 617-614-3523.
The access code for all callers is 83035324.
Through an audio replay: A replay of the conference call will be
available beginning at 11:30 a.m. on January 25, 2013, and ending at
5:00 p.m. on February 1, 2013. The dial-in number for U.S.
participants is 888-286-8010. For participants outside the U.S., the
replay dial-in number is 617-801-6888. The replay access code for all
callers is 90266221.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000
employees worldwide in 70 countries, and its products are sold in over
140 countries. Please visit www.covidien.com
to learn more about our business.
Eric Kraus, 508-261-8305
Senior Vice President
Lannum, CFA, 508-452-4343